These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1146 related articles for article (PubMed ID: 8820786)

  • 1. Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension.
    Girard C; Fargnoli JM; Godin-Ribuot D; Dutheil V; Maitrasse B; Girardet P; Arvieux CC
    J Heart Lung Transplant; 1996 Jul; 15(7):700-8. PubMed ID: 8820786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and inotropic effects of nitric oxide in pulmonary hypertension.
    Chen EP; Bittner HB; Davis RD; Van Trigt P
    J Surg Res; 1997 May; 69(2):288-94. PubMed ID: 9224395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low doses of inhaled nitric oxide in heart transplant recipients.
    Auler Júnior JO; Carmona MJ; Bocchi EA; Bacal F; Fiorelli AI; Stolf NA; Jatene AD
    J Heart Lung Transplant; 1996 May; 15(5):443-50. PubMed ID: 8771498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of haemodynamic effects of nitric oxide on post-capillary pulmonary hypertension induced by acute sino-aortic denervation.
    Galinier M; Rougé P; Fourcade J; Senard JM; Albenque JP; Balanescu S; Doazan JP; Montastruc JL; Bounhoure JP; Montastruc P
    Br J Pharmacol; 1997 Jan; 120(1):7-12. PubMed ID: 9117101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled nitric oxide reduction in systolic pulmonary artery pressure is less in patients with decreased left ventricular ejection fraction.
    Cujec B; Hurst T; McCuaig R; Antecol D; Mayers I; Johnson D
    Can J Cardiol; 1997 Sep; 13(9):816-24. PubMed ID: 9343030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension.
    Chen EP; Bittner HB; Davis RD; Van Trigt P
    Ann Thorac Surg; 1997 Jun; 63(6):1546-55. PubMed ID: 9205146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhalation nitric oxide during heart transplantation].
    Kozlov IA; Poptsov VN
    Anesteziol Reanimatol; 1999; (5):9-14. PubMed ID: 10560143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension.
    Curran RD; Mavroudis C; Backer CL; Sautel M; Zales VR; Wessel DL
    Ann Thorac Surg; 1995 Dec; 60(6):1765-71. PubMed ID: 8787478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
    Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
    J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
    J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide modifies left ventricular diastolic stress in the presence of vasoactive agents in heart failure.
    Natori S; Hasebe N; Jin YT; Matsusaka T; Ido A; Matsuhashi H; Ihara T; Kikuchi K
    Am J Respir Crit Care Med; 2003 Mar; 167(6):895-901. PubMed ID: 12519739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation.
    Wagner F; Dandel M; Günther G; Loebe M; Schulze-Neick I; Laucke U; Kuhly R; Weng Y; Hetzer R
    Circulation; 1997 Nov; 96(9 Suppl):II-291-6. PubMed ID: 9386113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled nitric oxide is not a myocardial depressant in a porcine model of heart failure.
    Argenziano M; Dean DA; Moazami N; Goldstein DJ; Rose EA; Spotnitz HM; Burkhoff D; Oz MC; Dickstein ML
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):700-8. PubMed ID: 9535459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction.
    Missant C; Rex S; Segers P; Wouters PF
    Crit Care Med; 2007 Mar; 35(3):707-15. PubMed ID: 17255859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled nitric oxide is not a negative inotropic agent in a porcine model of pulmonary hypertension.
    Goldstein DJ; Dean DA; Smerling A; Oz MC; Burkhoff D; Dickstein ML
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):461-6. PubMed ID: 9305200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
    Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.